📖 Approx. 9 min
Understanding Consumption Tax Treatment in Medical Corporation M&A
In M&A involving medical corporations, also known as medical practice succession, determining whether the transfer consideration is subject to consumption tax or exempt is a crucial point. This is particularly important because the amount of tax payable can fluctuate significantly depending on whether the transfer of assets held by the medical corporation falls under a “taxable transaction” as defined by the Consumption Tax Act. Generally, medical corporations engage in many transactions that are exempt from consumption tax, such as receiving fees related to social insurance medical treatment. However, in M&A scenarios, transactions such as the transfer of real estate, medical equipment, or the business itself may occur, which could be subject to consumption tax. This article explains the criteria for determining taxable versus non-taxable transactions in medical corporation M&A, provides specific transaction examples, and outlines key considerations from a practical standpoint. Collaboration with experts is essential for making appropriate judgments and achieving a smooth M&A process.
Transactions Subject to Consumption Tax vs. Non-Taxable Transactions
The Consumption Tax Act defines taxable transactions as “the transfer, lease, or provision of services of assets conducted by a business operator in Japan as a business for consideration.” In the context of medical corporation M&A, the following transactions are primarily relevant:
1. Transfer of Assets Held by a Medical Corporation
When a medical corporation transfers assets it holds as part of the M&A consideration, the consumption tax implications vary depending on the type of asset.
- Examples of Taxable Assets
- Real Estate (excluding land): Buildings, medical equipment, fixtures, vehicles, etc. The transfer of these assets is subject to tax, even if they were used in the business.
- Inventory Assets: Pharmaceuticals, medical consumables, etc.
- Securities (excluding those exempt): Stocks, bonds, etc.
- Examples of Non-Taxable Assets
- Land: The transfer and lease of land are non-taxable. However, consumption tax paid on the acquisition of land is generally not eligible for input tax credit.
- Rights related to Social Insurance Medical Treatment, etc.: Rights directly related to medical treatment, such as claims for medical fees, may be considered consideration for non-taxable transactions.
2. Consumption Tax Treatment in Business Transfers
When a medical corporation’s M&A is structured as a “business transfer,” it is crucial to determine whether the total value of the assets transferred as part of the business is subject to consumption tax. Generally, a business transfer involves the comprehensive assumption of assets, liabilities, and contracts belonging to the business being transferred. In such cases, the calculation of consumption tax can become complex, depending on whether the entire business being transferred is considered a taxable transaction or if it is assessed based on the transfer of individual assets and liabilities.
Nature of “Asset Transfer, etc.” under the Consumption Tax Act
Under the Consumption Tax Act, in the case of a business transfer, the determination is based on whether the transfer of assets falls under “asset transfer, etc.” If the assets of the business being transferred include those subject to consumption tax (e.g., buildings, medical equipment) and are transferred for consideration, they are generally taxable. Conversely, the transfer of assets that are non-taxable transactions (e.g., land) will naturally be non-taxable.
Comparison of “Business Transfer” and “Company Split”
Besides business transfer, a company split is another option for M&A structuring. In a company split, the split-acquiring company takes over assets and liabilities from the split-medical corporation. However, under the Consumption Tax Act, this is generally treated as not falling under “asset transfer, etc.” Therefore, company splits are sometimes considered as a scheme to avoid consumption tax burdens. Nevertheless, the tax implications can vary depending on the specific circumstances, such as when cash is paid as consideration for the split.
Key Points and Practical Considerations for Consumption Tax Determination in M&A
Determining whether transactions are taxable or non-taxable in medical corporation M&A is extremely important as it directly impacts the calculation of transfer consideration, the existence of tax liability, and the eligibility for input tax credit. The following are practical considerations:
1. Clarification of Consumption Tax Amount in Transfer Consideration
In M&A agreements, it is essential to clearly distinguish between the portion of the transfer consideration that is subject to consumption tax and the portion that is non-taxable, and to explicitly state this in the contract. For example, it is common to state that consumption tax applies to the transfer of buildings and medical equipment, and to calculate and display this tax amount separately.
【Points to Note Regarding Display of Consumption Tax Amount】
The method of displaying and calculating consumption tax differs depending on whether the transfer consideration is on an “inclusive tax basis (tax-included amount)” or an “exclusive tax basis (tax-excluded amount).” It is necessary to clarify which method will be adopted before concluding the contract.
2. Determination of Taxable Business Operator vs. Tax-Exempt Business Operator
It is also important to determine whether the medical corporation on the transfer side will be classified as a taxable business operator or a tax-exempt business operator for the transactions involved in the M&A (e.g., transfer of taxable assets). If classified as a taxable business operator, the corporation will have an obligation to pay the consumption tax amount related to the transaction to the government. Conversely, a tax-exempt business operator has no obligation to pay consumption tax but cannot claim input tax credits.
Determination Based on Taxable Sales in the Base Period
The determination of whether a business is taxable or tax-exempt is generally made based on whether the taxable sales in the base period (the second fiscal year prior to the current one) exceed 10 million yen. Depending on the timing of the M&A, there may be cases where taxable asset transfers temporarily occur, and if these taxable sales are added to the taxable sales of the base period, the corporation may become a taxable business operator from the following taxable period. It is recommended to conduct simulations in collaboration with experts regarding this matter.
3. Applicability of Input Tax Credit
If the transferor is a taxable business operator, it is necessary to consider whether input tax credit can be applied to the consumption tax paid in connection with the M&A transaction (consumption tax on purchases). Input tax credit is a system for calculating the tax payable by subtracting the consumption tax paid on purchases and expenses from the consumption tax on sales. Whether the consumption tax paid on the purchase of medical equipment or the acquisition of real estate is eligible for input tax credit depends on whether the asset is used solely for taxable sales (transfers of taxable assets, etc.), solely for non-taxable sales (non-taxable transactions), or for both (common-use assets).
4. Importance of Consulting Experts
Due to the complexity and high level of expertise required, consulting with a tax accountant, particularly one specializing in the medical field, is indispensable for determining the consumption tax treatment in medical corporation M&A. The optimal judgment and tax strategies vary significantly depending on the specific situation of each medical corporation, the nature of the assets being transferred, and the M&A structure. Early collaboration with experts to accurately grasp consumption tax-related risks and implement appropriate measures will lead to a smooth and favorable M&A.
Calculation of Transfer Consideration and Its Relation to Consumption Tax
The treatment of consumption tax has a direct impact on the calculation of transfer consideration in M&A. If the transfer includes assets subject to consumption tax, failure to clarify how the consumption tax amount will be included in the transfer consideration or added separately can significantly alter the final net proceeds.
Classification of Taxable and Non-Taxable Assets
The first step is to clearly classify the assets transferred in the M&A into taxable assets (e.g., buildings, medical equipment) and non-taxable assets (e.g., land) under the Consumption Tax Act and calculate their respective values. If the transfer consideration is calculated without a clear distinction, there is a risk of being cited during tax audits later.
Example of Transfer Consideration Calculation Method
For instance, assume Medical Corporation A transfers its business to Medical Corporation B through M&A, and the assets transferred include a building (market value 100 million yen, non-taxable for consumption tax) and medical equipment (market value 50 million yen, subject to consumption tax). In this case, even if the total transfer consideration is 150 million yen, consumption tax (e.g., 5 million yen at 10%) will be levied separately on the 50 million yen for the transfer of medical equipment, which is subject to consumption tax. The final net proceeds for Medical Corporation A will differ depending on whether the transfer consideration is displayed as “Total 150 million yen (consumption tax excluded)” or “Total 150 million yen (consumption tax included).” Furthermore, while various valuation methods such as DCF (Discounted Cash Flow) and comparable transaction methods are used for calculating transfer consideration, it is important to reach a final agreement after considering the consumption tax implications, regardless of the method used.
| Asset Transferred | Consumption Tax Classification | Remarks |
|---|---|---|
| Land | Non-Taxable | Both transfer and lease are non-taxable. |
| Building (Structure) | Taxable | Subject to consumption tax. |
| Medical Equipment | Taxable | Subject to consumption tax. |
| Pharmaceuticals/Consumables | Taxable | Subject to consumption tax. |
| Claims for Medical Fees | Non-Taxable | Considered as consideration for social insurance medical treatment. |
| Stocks (Unlisted) | Non-Taxable | If not considered “securities” under the Financial Instruments and Exchange Act. |
| Stocks (Listed or Unlisted) | Non-Taxable | If considered “securities” under the Financial Instruments and Exchange Act, non-taxable (however, excluding cases where the consideration for transfer, etc., is subject to consumption tax due to the nature of the business). |
Consumption Tax Filing and Payment in Medical Corporation M&A
After the M&A transaction is completed, both the transferor and transferee may be required to file and pay consumption tax. This is particularly true for the transferor if it is a taxable business operator and has transferred assets subject to tax, in which case prompt filing and payment are required.
- Transferor’s (Seller’s) Filing and Payment
A medical corporation that has transferred assets subject to tax through M&A must submit a final consumption tax return for the relevant taxable period to the competent tax office. The filing deadline is generally within two months from the day following the end of the taxable period. The amount payable is calculated by subtracting the consumption tax on purchases, etc., from the consumption tax on sales. - Points to Note for the Transferee (Buyer)
For the transferee (buyer) to be eligible for input tax credit on the consumption tax paid when acquiring taxable assets (buildings, medical equipment, etc.) through M&A, they generally need to retain qualified invoices (invoices) that comply with the “Qualified Invoice Retention System (Invoice System).” Depending on the M&A structure and transaction details, there may be cases where the transferee cannot claim input tax credit. Therefore, it is important to consult with experts in advance to confirm the system for receiving and storing invoices.
【The Invoice System and M&A】
With the introduction of the Invoice System, the treatment of consumption tax in M&A has become even more complex. Whether the transferor is an invoice issuer, and whether the transferee can reliably receive and store invoices to claim input tax credit, can influence the negotiation of M&A terms. It is wise to thoroughly discuss the response to the Invoice System with experts from the M&A consideration stage.
Consulting Experts for Consumption Tax in Medical Corporation M&A
The treatment of consumption tax in medical corporation M&A requires specialized knowledge due to its complexity. In particular, there are numerous issues to consider, including the calculation of transfer consideration, determination of taxable vs. non-taxable transactions, application of input tax credit, and compliance with the Invoice System. To make appropriate judgments and achieve a smooth M&A, consulting with experts such as tax accountants specializing in the medical field and M&A advisors is extremely important.
Benefits of Consulting Experts
- Accurate Tax Judgments: Accurate determination of taxable vs. non-taxable transactions can be made based on the specifics of each transaction and the nature of the assets.
- Consideration of Tax Saving Measures: Consumption tax burdens can be considered from the M&A structuring stage, and tax-saving measures within legal boundaries can be proposed.
- Support for Contract Drafting: Assistance can be provided to ensure that clauses related to consumption tax in the contract avoid risks and are fair to both parties.
- Smooth Tax Filing: Consumption tax filing and payment procedures after M&A can be carried out accurately and smoothly.
Medical corporation M&A is not merely a transfer of assets but a succession of a business, and it is a significant decision that impacts the future healthcare provision system. Clarifying consumption tax-related issues is an indispensable element for increasing the probability of M&A success. At M&A Medical, our specialized team for medical corporation M&A and business succession handles all consultations regarding tax, legal, and financial matters, including consumption tax. We will propose the optimal M&A strategy tailored to your institution’s situation, so please feel free to consult with us.
Consult M&A Medical for Medical Succession
M&A Medical is a specialized M&A and business succession support service for medical institutions. As an M&A support institution certified by the Small and Medium Enterprise Agency, we support everything from the transfer of clinics and medical corporations facing succession issues to strategic acquisitions, on a success fee basis.
- Initial consultation and preliminary assessment are free.
- No upfront fees or monthly charges (success fee only).
- Strict confidentiality (proceeds under NDA).
- Service available nationwide across all 47 prefectures and all medical specialties.
Please consult us early for any inquiries, such as “just want to know the market value,” “have no successor,” or “considering joining a group.”